Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

595 trials

NCT07509086
Recruiting
IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia
Phase 2 · China · 1 site
Registry update: 3 Apr 2026
NCT07226934
Recruiting
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
Not applicable · United States · 1 site
Registry update: 8 Oct 2026
NCT07319897
Recruiting
68Ga-BCMA PET/CT in Multiple Myeloma
Phase 2/3 · China · 5 sites
Registry update: 22 Jun 2026
NCT06932562
Recruiting
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
Phase 3 · Austria, Australia, Belgium, Switzerland, Czechia, Germany, Denmark, Estonia, Spain, Finland, Greece, Croatia, Ireland, Italy, Netherlands, Norway, Portugal, Sweden · 79 sites
Registry update: 25 Mar 2026
NCT07032714
Recruiting
Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma
Phase 1 · United States · 3 sites
Registry update: 13 Apr 2026
NCT07285044
Recruiting
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Phase 2 · United States · 1 site
Registry update: 30 Sept 2026
NCT06323447
Recruiting
Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia
Not applicable · Spain, United States · 6 sites
Registry update: 3 Nov 2026
NCT07309497
Recruiting
Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT Trial)
Not applicable · Switzerland · 2 sites
Registry update: 30 Dec 2025
NCT07107529
Recruiting
Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.
Phase 2 · Spain, Italy, Netherlands, Norway · 29 sites
Registry update: 15 Apr 2026
NCT07294625
Recruiting
A Clinical Study to Evaluate LVIVO-TaVec200 for the Treatment of Relapsed/Refractory Multiple Myeloma
Early phase 1 · China · 5 sites
Registry update: 19 Dec 2025
NCT07179679
Recruiting
A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell Tumors
Phase 1 · China · 14 sites
Registry update: 11 Dec 2025
NCT06247189
Recruiting
ICOPE Program Feasibility in the Management of Myeloma Patients
Not applicable · France · 1 site
Registry update: 22 Dec 2025
NCT06910124
Recruiting
Linvoseltamab in Addition to Lenalidomide (L2) During Maintenance Therapy of NDMM to Deepen Responses or Redrive MRD Negativity After Relapse
Phase 2 · United States · 1 site
Registry update: 8 Jan 2026
NCT07093554
Recruiting
Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma
Phase 1 · United States · 1 site
Registry update: 5 Jan 2026
NCT06514508
Recruiting
Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients
Phase 3 · China · 2 sites
Registry update: 14 Sept 2026
NCT07448935
Recruiting
One Gene, Two Diseases: the Pathologic Role of IGLV1-44 in AL Amyloidosis and POEMS
Not applicable · Italy · 1 site
Registry update: 6 May 2026
NCT07040189
Recruiting
Gustabor Phase 1 - AI-based Creation of a Nutritional Plan to Compensate for Chemotherapy-induced Taste Disorders
Not applicable · Germany · 3 sites
Registry update: 21 Aug 2026
NCT07236021
Recruiting
e-Motion : Promoting Emotion Regulation in Chronic Cancer
Not applicable · Belgium · 2 sites
Registry update: 21 Nov 2025
NCT06827860
Recruiting
Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse
Phase 2 · United States · 1 site
Registry update: 14 Sept 2026
NCT07448779
Recruiting
Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment
Not applicable · Italy · 1 site
Registry update: 4 Mar 2026

Ordered by registry start date. Freshness and sponsorship never change the order.